A phase 11 Non randomised Study of Modrenal in Pre-menopausal Women with Advanced Oestrogen Receptor Positive Breast Cancer who have relapsed or are refractory to Hormone Therapies of Tamoxifen, Goserelin & an Aromatase Inhib (Bioenvision).

  • Rea, Daniel (Principal Investigator)

Project Details

Short titleA phase 11 Non randomised Study of Modrenal in Pre-menopausal Women with Advanced Oestrogen Receptor Positive Breast Cancer who have relapsed or are refractory to Hormone Therapies of Tamoxifen, Goserelin & an Aromatase Inhib (Bioenvision).
StatusFinished
Effective start/end date1/06/05 → 30/04/07

Funding

  • Queen Elizabeth Hospital Birmingham